XML 58 R47.htm IDEA: XBRL DOCUMENT v3.24.3
Related Party Transactions (Details) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Aug. 31, 2024
Dec. 31, 2022
Mar. 31, 2016
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2023
Related Party Transaction [Line Items]                    
Research and development expenses       $ 18,733,584 $ 15,503,032 $ 62,734,891 $ 69,423,513      
Accounts receivable       1,862,739   1,862,739       $ 2,405,228
The Wistar Institute                    
Related Party Transaction [Line Items]                    
Collaborative agreement, amended amount               $ 13,600,000    
Affiliated Entity                    
Related Party Transaction [Line Items]                    
Expenses to reimburse     $ 3,100,000              
Collaborative arrangement, term (in years)     5 years              
Contra-research and development expense       153,000 316,000 302,000 705,000      
Affiliated Entity | The Wistar Institute                    
Related Party Transaction [Line Items]                    
Awarded amount   $ 1,200,000       2,400,000     $ 10,700,000  
Collaborative agreement, amended amount $ 12,500,000                  
Awarded option amount           4,200,000        
Research and development expenses       296,000 $ 407,000 1,300,000 $ 1,300,000      
Accounts receivable       1,900,000   1,900,000       2,400,000
Accounts payable and accrued liabilities, current       1,800,000   1,800,000       1,100,000
Deferred grant funding, from affiliate       $ 0   $ 0       $ 22,000
Plumbline Life Sciences                    
Related Party Transaction [Line Items]                    
Investment owned (in shares)       597,808   597,808        
Non-controlling interest (in percent)       17.80%   17.80%